David D. Davidar - 13 Sep 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
13 Sep 2024
Net transactions value
-$1,123,500
Form type
4
Filing time
17 Sep 2024, 16:31:33 UTC
Previous filing
10 May 2024
Next filing
18 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $638,000 +25,000 +4.4% $25.52 591,275 13 Sep 2024 Direct
transaction GMED Class A Common Stock Sale $1,761,500 -25,000 -4.2% $70.46 566,275 13 Sep 2024 Direct F1
holding GMED Class A Common Stock 205,967 13 Sep 2024 By Davidar Family Irrevocable Trust U/A 8/6/09 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -25,000 -50% $0.000000 25,000 13 Sep 2024 Class A Common Stock 25,000 $25.52 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $70.20 - $70.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
F2 These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
F3 These options were granted on January 25, 2016 and are fully vested.